ARCHIVES

NCI Officials Open To Fine-Tuning Group Budgets As Advocates Chip Away At NCTN’s Façade

This article is from The Cancer Letter archive.

Vol. 40 No. 18 | May 2, 2014

Download PDF Visit The Full Archive

Related Articles

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

NCI Director Harold Varmus Plans New Center For Cancer Genomics To Lead The Cancer Genome Atlas Program.

September 10, 2010

ACCC Enthusiastically Support New Effort Or Clinical Research

April 3, 1981

Field Studies Chief Leave For Job with Upton; Sibal Named DCCP Acting Deputy

October 27, 1978

Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?

April 16, 1999

Public Participation Hearings Develop Gals for Reducing Cancer Mortality

February 17, 1989